Related Experiment Video

Updated: Jul 7, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

[Diabetes mellitus in children in Lomé (Togo)]

Adama Dodji Gbadoé1, Raymond Barruet, Koko Lawson-Evi

  • 1Service de pédiatrie, CHU-Tokoin Lomé, Togo.

La Tunisie Medicale
|February 8, 2008
PubMed

Insights

The emergence of type 2 diabetes mellitus (T2DM) in children in Lomé, Togo, is characterized by obesity and a family history of diabetes. Early diagnosis and management, including lifestyle changes, are crucial for successful treatment outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Context:

  • Diabetes mellitus in children presents unique challenges in resource-limited settings.
  • Understanding the epidemiological shifts in diabetes types is critical for public health.
  • Lomé, Togo, serves as a specific geographical focus for this pediatric diabetes study.

Purpose:

  • To describe the clinical characteristics and outcomes of children diagnosed with diabetes mellitus in Lomé, Togo.
  • To differentiate between type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and corticosteroid-induced diabetes in pediatric patients.
  • To identify key risk factors associated with T2DM in the pediatric population.

Summary:

  • The study analyzed 18 children admitted for diabetes between 1997 and 2004.
  • Diagnoses included 12 T1DM, 5 T2DM, and 1 corticosteroid-induced diabetes.
  • T2DM risk factors identified were obesity and familial history; T1DM also showed familial links.
  • Clinical presentations often included polyuria, polydipsia, and ketonuria.
  • T2DM patients were obese with unhealthy lifestyle factors; T1DM patients required insulin, while T2DM patients were managed with insulin, exercise, and diet.

Impact:

  • Highlights the increasing prevalence of T2DM in children in Togo, shifting the clinical landscape.
  • Emphasizes the role of obesity and genetics in pediatric T2DM.
  • Informs public health strategies and clinical management guidelines for childhood diabetes in similar regions.
  • Demonstrates successful treatment modalities for both T1DM and T2DM in pediatric populations.
Abstract

More Related Videos

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes08:03

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Published on: June 25, 2017

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...